95 results
8-K
EX-99.1
TNDM
Tandem Diabetes Care Inc
2 May 24
Tandem Diabetes Care Announces First Quarter 2024 Financial Results
4:07pm
expenses:
Selling, general and administrative
Research and development
Acquired in-process research and development expenses
Total operating expenses … (1)
Non-GAAP gross profit
GAAP gross margin(2)
Non-GAAP gross margin(3)
GAAP operating loss
Acquired in-process research and development(4)
Severance
8-K
EX-99.1
TNDM
Tandem Diabetes Care Inc
21 Feb 24
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results
4:09pm
and development
Acquired in-process research and development expenses
Total operating expenses
Operating loss
Total other income (expense), net
Loss before … loss
Acquired in-process research and development(3)
Non-recurring facility consolidation costs(4)
Severance costs - cash and noncash
Adjustment
8-K
EX-99.1
qyrdp bd2gb5usu7oal
1 Nov 23
Tandem Diabetes Care Announces Third Quarter 2023 Financial Results
4:03pm
8-K
EX-99.1
w8hr5k606a qateuq0tq
3 Aug 23
Tandem Diabetes Care Announces Second Quarter 2023 Financial Results
4:04pm
8-K
EX-99.1
y31sw 9mqp36hb47ylq7
3 May 23
Tandem Diabetes Care Announces First Quarter 2023 Financial Results
4:08pm
8-K
EX-99.1
wjj6syh
2 Nov 22
Tandem Diabetes Care Announces Third Quarter 2022 Financial Results
4:07pm
8-K
EX-99.1
jm1bao
3 Aug 22
Tandem Diabetes Care Announces Second Quarter 2022 Financial Results
4:08pm
8-K
EX-99.1
mf94rh
4 May 22
Tandem Diabetes Care Announces First Quarter 2022 Financial Results
4:11pm